WikiStock

Global Securities Firms Regulatory Inquiry App

English
Download
Home-News-

Cathie Wood's Ark Invest Acquires $7.3M Worth Of Shares In This Promising Netflix Competitor, Sells Off C

iconBenzinga

2024-06-27 07:33

On Wednesday, Cathie Wood-led Ark Invest made significant trades in Roku Inc (NASDAQ:ROKU) and Coinbase Global Inc (NASDAQ:COIN), amidst a volatile market.

  On Wednesday, Cathie Wood-led Ark Investmade significant trades in Roku IncROKU and Coinbase Global IncCOIN, amidst a volatile market. These prominent trades were part of a series of transactions carried out by Arks various ETFs.

  The ROKU Trade

  ARK Innovation ETFARKK and ARK Next Generation InternetETF ARKW bought 127,540 shares in Roku Inc. The ARKK fund acquired 106,420 shares, while the ARKW fund added 21,120 shares. The transaction amounted to $7.3 million. On Wednesday, Roku shares closed 4.6% higher at $57.16 in the regular session.

  Notably, Wood‘s firm purchased $5.3 million worth of Roku shares a day earlier. These moves come amidst Roku’s turbulent market journey with the stock caught between a fierce bull-bear debate.

  Roku, a TV streaming platform and a rival of streaming platforms such as Netflix, recently launched Roku Exchange, an advertising technology solution that bridges ad inventory with advertiser demand directly.

  The COIN Trade

  Ark Invests ARKW ETF sold 3,278 shares of Coinbase worth $703,393. This sale comes in the wake of a significant transfer of cryptocurrency to Coinbase by wallets believed to be linked to the U.S. government. The U.S. government transferred 3,940 BitcoinBTC/USD, valued at $241 million, to Coinbase.

  This move by the U.S. government caused the cryptocurrency market to edge lower. Bitcoin slipped below $61,000, following a modest bounce to $62,000 in previous trading sessions.

  Other Key Trades:

  • Ark Invests ARKG ETF sold shares of Ginkgo Bioworks Holdings IncDNA and bought shares of 10X Genomics IncTXG.
  • The ARKG fund also sold shares of Teladoc Health IncTDOC and bought shares of Intellia Therapeutics IncNTLA.

  This story was generated using Benzinga Neuro and edited by Shivdeep Dhaliwal

  © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Disclaimer:The views in this article only represent the author's personal views, and do not constitute investment advice on this platform. This platform does not guarantee the accuracy, completeness and timeliness of the information in the article, and will not be liable for any loss caused by the use of or reliance on the information in the article.